Skip to content

Clinical trials

Completed Hypersensitivity trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Status: Completed Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20102
20141
20161
20171
20181
20191
20212
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brugmann University Hospital2
Celgene2
ALK-Abelló A/S1
AstraZeneca1
BioTech Tools S.A.1
GlaxoSmithKline1
Hippocreates1
Pfizer1
Société des Produits Nestlé (SPN)1
St. Antonius Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity16
Hypersensitivity, Immediate3
Immune System Diseases3
Eosinophilia2
Eosinophilic Esophagitis2
Esophageal Diseases2
Esophagitis2
Gastroenteritis2
Gastrointestinal Diseases2
Anaphylaxis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.